FDA Inspection 1261641 — Relevium Labs Inc
The FDA completed an inspection of Relevium Labs Inc on Feb 12, 2025 in Oxford, OH. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 12, 2025
- Fiscal Year
- 2025
- Product Type
- Devices
- Project Area
- Compliance: Devices
- Location
- Oxford, OH (United States)